Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Net Shares Issued and Repurchased (2010 - 2017)

Insmed (INSM) posted Net Shares Issued and Repurchased of $940060.0 for Q1 2017, down 62.88% on a QoQ basis from $2.5 million in Q4 2016, and down 4.9% year-over-year from $988500.0 in Q1 2016.

Analysis

Insmed (INSM) Net Shares Issued and Repurchased (2010 - 2017) Analysis & Trends

Insmed has reported Net Shares Issued and Repurchased for 8 years, with the latest figure at $940060.0 in Q1 2017.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 4.9% year-over-year to $940060.0 in Q1 2017; TTM through Mar 2017 was $940060.0, a 4.9% decrease from a year earlier, with the FY2016 full-year figure at $2.5 million, up 33.1% from the prior year.
  • Net Shares Issued and Repurchased was $940060.0 for Q1 2017 at Insmed, down from $2.5 million in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $2.5 million in Q4 2016, with the low at -$150000.0 in Q3 2014.
  • Average Net Shares Issued and Repurchased over 5 years is $1.2 million, with a median of $964280.0 recorded in 2016.
  • The sharpest annual moves came in 2013 and 2014: Net Shares Issued and Repurchased soared 108.13% in 2013, then tumbled 31.12% in 2014.
  • Over 5 years, Net Shares Issued and Repurchased stood at $2.3 million in 2013, then slumped by 31.12% to $1.6 million in 2014, then grew by 18.89% to $1.9 million in 2015, then surged by 33.1% to $2.5 million in 2016, then slumped by 62.88% to $940060.0 in 2017.
  • The last three Net Shares Issued and Repurchased figures came in at $940060.0 (Q1 2017), $2.5 million (Q4 2016), and $988500.0 (Q1 2016), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 940,060.00
Dec 31, 2016 2.53 Mn
Mar 31, 2016 988,500.00
Dec 31, 2015 1.90 Mn
Mar 31, 2015 619,150.00
Dec 31, 2014 1.60 Mn
Sep 30, 2014 -150,000.00
Mar 31, 2014 649,050.00
Dec 31, 2013 2.32 Mn
Mar 31, 2013 552,250.00
Dec 31, 2012 1.12 Mn
Dec 31, 2011 766,000.00
Dec 31, 2010 45,000.00